# OnCo record small-bowel (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/small-bowel/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "small-bowel" ;
  schema:name "Small intestine cancer (small bowel adenocarcinoma)"@en ;
  schema:alternateName "Small bowel adenocarcinoma"@en, "Duodenal cancer"@en, "Jejunal and ileal cancer"@en, "SBA"@en ;
  schema:description "Cancers of the small intestine are rare and often found late because the small bowel is hard to see and symptoms are vague. Surgery cures early disease, chemotherapy borrowed from bowel cancer helps after surgery and in advanced disease, and a large minority of tumours have a repair defect that makes them respond well to immunotherapy."@en ;
  schema:url <https://onco.cc/cancers/small-bowel/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Small_intestine_cancer> ;
  schema:citation <https://www.cancer.gov/types/small-intestine>, <https://www.asco.org/guidelines>, <https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1490>, <https://clinicaltrials.gov/study/NCT02502370>, <https://seer.cancer.gov/statfacts/html/smint.html> ;
  onco:tag "nci-coverage", "rare", "gastrointestinal" ;
  onco:related <https://onco.cc/cancers/neuroendocrine/>, <https://onco.cc/cancers/gist/>, <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/ampullary/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/terms/endoscopy/>, <https://onco.cc/technologies/mri/>, <https://onco.cc/technologies/cgp/>, <https://onco.cc/technologies/germline-testing/> ;
  onco:targets <https://onco.cc/targets/her2/>, <https://onco.cc/targets/kras/>, <https://onco.cc/targets/pd1/> ;
  onco:drugs <https://onco.cc/drugs/capox/>, <https://onco.cc/drugs/folfox/>, <https://onco.cc/drugs/folfiri/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/paclitaxel/>, <https://onco.cc/drugs/trastuzumab-deruxtecan/> ;
  onco:pathways <https://onco.cc/pathways/mismatch-repair-msi/>, <https://onco.cc/pathways/ras-mapk/>, <https://onco.cc/pathways/wnt/> ;
  onco:terms <https://onco.cc/terms/msi/>, <https://onco.cc/terms/lynch-syndrome/>, <https://onco.cc/terms/hereditary-cancer-syndromes/>, <https://onco.cc/terms/whipple/>, <https://onco.cc/terms/lymphadenectomy/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-rare-cancers/>, <https://onco.cc/bottlenecks/b-trial-enrolment/>, <https://onco.cc/bottlenecks/b-early-detection/> ;
  onco:pipeline <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/trastuzumab-deruxtecan/>, <https://onco.cc/drugs/signatera/> ;
  onco:standardOfCare <https://onco.cc/terms/whipple/>, <https://onco.cc/terms/lymphadenectomy/>, <https://onco.cc/drugs/capox/>, <https://onco.cc/drugs/folfox/>, <https://onco.cc/trials/ballad/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/terms/msi/>, <https://onco.cc/pathways/mismatch-repair-msi/>, <https://onco.cc/drugs/capox/>, <https://onco.cc/drugs/folfox/>, <https://onco.cc/drugs/folfiri/>, <https://onco.cc/drugs/paclitaxel/> .